Preventive strategies for hereditary breast cancer pre-disposition;Präventive strategien bei familiärer brustkrebsprädisposition

Radiologe

Volumn 41, Issue 4, 2001, Pages 366-370

  Kiechle, M ^a   Schmutzler, R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

BRCA1; BRCA2; Hereditary Breast Cancer; Prevention

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CANCER SUSCEPTIBILITY; CONSULTATION; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; ONCOGENE; REVIEW; SECONDARY PREVENTION;

EID: 18244413341     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170051015     Document Type: Review

References (25)

1. Integriertes früherkennungs konzept bei frauen mit genetischer prädisposition für Brustkrebs
2. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium
3. Exclusion of major role for the PTEN tumour suppressor gene in breast carcinomas
4. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
5. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
6. Linkage of early onset familial breast cancer to chromosome 17q21
7. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
8. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results
9. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
10. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
11. Ovarian cancer: Screening, treatment, and follow up
12. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
13. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
14. BRCA2 in American families with four or more cases of breast or ovarian cancer: Rcurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2
15. Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer susceptibility genes?
16. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: Linkage analysis in German breast cancer families
17. Allele losses in the region 17q12-21 in familial breast and ovarian cancerinvolve the wild-type chromosome
18. Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer
19. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
20. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes
21. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study
22. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13